PRF1 and Miyoshi myopathy: Bispecific antibodies (BsAbs) are molecules that bind simultaneously to the tumor binding domain (such as BCMA) of MM cells and CD3-positive T cells, resulting in perforin and granzymes-mediated MM cell lysis [29].